
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $343.5K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $3.3M | |
Gross Profit | -- | -- | -- | -- | -$3M | |
Gross Profit Margin | -- | -- | -- | -- | -862.07% | |
R&D Expenses | -- | $857.6K | $963.4K | $7.6M | $14.3M | |
Selling, General & Admin | $4.1M | $36.3M | $31.7M | $12.8M | $16.1M | |
Other Inc / (Exp) | -$4.5M | -$733.2K | $9.4K | $365.6K | -$10.6M | |
Operating Expenses | $4.4M | $37.7M | $33.5M | $22.4M | $34.6M | |
Operating Income | -$4.4M | -$37.7M | -$33.5M | -$22.4M | -$37.5M | |
Net Interest Expenses | -- | -- | -- | -- | $4.4M | |
EBT. Incl. Unusual Items | -$13.3M | -$41.8M | -$33.5M | -$22.2M | -$52.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$13.3M | -$41.8M | -$33.5M | -$22.2M | -$52.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$13.3M | -$41.8M | -$33.5M | -$22.2M | -$52.5M | |
Basic EPS (Cont. Ops) | -$0.75 | -$1.20 | -$0.80 | -$0.51 | -$1.02 | |
Diluted EPS (Cont. Ops) | -$0.75 | -$1.20 | -$0.80 | -$0.51 | -$1.02 | |
Weighted Average Basic Share | $17M | $33.2M | $41.7M | $43.8M | $51.2M | |
Weighted Average Diluted Share | $17M | $33.2M | $41.7M | $43.8M | $51.2M | |
EBITDA | -$8.9M | -$38.8M | -$33.4M | -$21.9M | -$50.6M | |
EBIT | -$8.9M | -$38.8M | -$33.5M | -$22.1M | -$52.3M | |
Revenue (Reported) | -- | -- | -- | -- | $343.5K | |
Operating Income (Reported) | -$4.4M | -$37.7M | -$33.5M | -$22.4M | -$37.5M | |
Operating Income (Adjusted) | -$8.9M | -$38.8M | -$33.5M | -$22.1M | -$52.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $980K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $3.7M | |
Gross Profit | -- | -- | -- | -- | -$2.7M | |
Gross Profit Margin | -- | -- | -- | -- | -274.49% | |
R&D Expenses | -- | $138.3K | $1.5M | $4M | $3.3M | |
Selling, General & Admin | $6.8M | $2.5M | $3.5M | $3.2M | $3.7M | |
Other Inc / (Exp) | $2.6M | $209K | $24K | -$235.9K | $43.6K | |
Operating Expenses | $6.8M | $2.8M | $5.6M | $8.6M | $8M | |
Operating Income | -$6.8M | -$2.8M | -$5.6M | -$8.6M | -$10.6M | |
Net Interest Expenses | -- | -- | -- | -- | $894.4K | |
EBT. Incl. Unusual Items | -$4.9M | -$2.6M | -$5.6M | -$10M | -$11.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.9M | -$2.6M | -$5.6M | -$10M | -$11.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.9M | -$2.6M | -$5.6M | -$10M | -$11.5M | |
Basic EPS (Cont. Ops) | -$0.15 | -$0.06 | -$0.13 | -$0.19 | -$0.14 | |
Diluted EPS (Cont. Ops) | -$0.15 | -$0.06 | -$0.13 | -$0.19 | -$0.14 | |
Weighted Average Basic Share | $33.8M | $42.3M | $43.5M | $52M | $85.1M | |
Weighted Average Diluted Share | $33.8M | $42.3M | $43.5M | $52M | $85.1M | |
EBITDA | -$4.2M | -$2.6M | -$5.6M | -$8.8M | -$9.3M | |
EBIT | -$4.2M | -$2.6M | -$5.6M | -$8.8M | -$10.6M | |
Revenue (Reported) | -- | -- | -- | -- | $980K | |
Operating Income (Reported) | -$6.8M | -$2.8M | -$5.6M | -$8.6M | -$10.6M | |
Operating Income (Adjusted) | -$4.2M | -$2.6M | -$5.6M | -$8.8M | -$10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $1.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $12.8M | |
Gross Profit | -- | -- | -- | -- | -$11M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $3.8M | $15.2M | $11.4M | |
Selling, General & Admin | $33.5M | $30.4M | $15.5M | $14.1M | $21.8M | |
Other Inc / (Exp) | -$4M | $486.2K | $97.7K | -$255.4K | -$9.7M | |
Operating Expenses | $33.9M | $32.8M | $21.2M | $33.5M | $35.4M | |
Operating Income | -$33.9M | -$32.8M | -$21.2M | -$33.5M | -$46.3M | |
Net Interest Expenses | -- | -- | -- | -- | $4M | |
EBT. Incl. Unusual Items | -$43.6M | -$32.3M | -$21.1M | -$37M | -$60M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$43.6M | -$32.3M | -$21.1M | -$37M | -$60M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$43.6M | -$32.3M | -$21.1M | -$37M | -$60M | |
Basic EPS (Cont. Ops) | -$1.65 | -$0.66 | -$0.53 | -$0.77 | -$0.92 | |
Diluted EPS (Cont. Ops) | -$1.65 | -$0.66 | -$0.53 | -$0.77 | -$0.92 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$38.2M | -$32.3M | -$20.9M | -$33.2M | -$55.9M | |
EBIT | -$38.2M | -$32.3M | -$21.1M | -$33.5M | -$61.4M | |
Revenue (Reported) | -- | -- | -- | -- | $1.9M | |
Operating Income (Reported) | -$33.9M | -$32.8M | -$21.2M | -$33.5M | -$46.3M | |
Operating Income (Adjusted) | -$38.2M | -$32.3M | -$21.1M | -$33.5M | -$61.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $1.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $9.5M | |
Gross Profit | -- | -- | -- | -- | -$8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $622.5K | $3.5M | $11.1M | $8.2M | |
Selling, General & Admin | $31.7M | $25.8M | $9.4M | $10.7M | $16.3M | |
Other Inc / (Exp) | -$970.6K | $248.8K | $150.2K | -$470.8K | $460.9K | |
Operating Expenses | $31.8M | $26.9M | $14.4M | $25.4M | $26.2M | |
Operating Income | -$31.8M | -$26.9M | -$14.4M | -$25.4M | -$34.2M | |
Net Interest Expenses | -- | -- | -- | -- | $2.8M | |
EBT. Incl. Unusual Items | -$36.1M | -$26.7M | -$14.2M | -$29.1M | -$36.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$36.1M | -$26.7M | -$14.2M | -$29.1M | -$36.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$36.1M | -$26.7M | -$14.2M | -$29.1M | -$36.6M | |
Basic EPS (Cont. Ops) | -$1.20 | -$0.66 | -$0.33 | -$0.59 | -$0.49 | |
Diluted EPS (Cont. Ops) | -$1.20 | -$0.66 | -$0.33 | -$0.59 | -$0.49 | |
Weighted Average Basic Share | $93.8M | $124M | $129.6M | $145.9M | $229.9M | |
Weighted Average Diluted Share | $93.8M | $124M | $129.6M | $145.9M | $229.9M | |
EBITDA | -$33.2M | -$26.7M | -$14.1M | -$25.5M | -$31.1M | |
EBIT | -$33.2M | -$26.7M | -$14.2M | -$25.7M | -$34.9M | |
Revenue (Reported) | -- | -- | -- | -- | $1.5M | |
Operating Income (Reported) | -$31.8M | -$26.9M | -$14.4M | -$25.4M | -$34.2M | |
Operating Income (Adjusted) | -$33.2M | -$26.7M | -$14.2M | -$25.7M | -$34.9M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $829.9K | $12.8M | $29M | $2.3M | $7M | |
Short Term Investments | -- | -- | $21K | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $228.5K | |
Inventory | -- | -- | -- | $125.2K | $154.3K | |
Prepaid Expenses | $237.3K | $1.3M | $878.8K | $1.6M | $1.8M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.1M | $14.1M | $29.9M | $4.8M | $18.4M | |
Property Plant And Equipment | $58.8K | $5.5M | $19.1M | $38.3M | $54.8M | |
Long-Term Investments | $35.3K | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | $1.6M | $3.9M | $3.9M | $4.5M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.2M | $21.3M | $52.9M | $74.7M | $77.7M | |
Accounts Payable | $514.8K | $1.6M | $344.1K | $1.8M | $4.3M | |
Accrued Expenses | -- | -- | $2.6M | $5.8M | $5M | |
Current Portion Of Long-Term Debt | $8.6K | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $99.8K | $121.5K | $54.3K | |
Other Current Liabilities | $4.5M | -- | -- | -- | -- | |
Total Current Liabilities | $5.8M | $1.8M | $3.1M | $13.7M | $15.8M | |
Long-Term Debt | $306.7K | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.1M | $1.8M | $3.2M | $13.8M | $16.2M | |
Common Stock | $365.5K | $2.7M | $42.9K | $45.9K | $64.1K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$4.9M | $17.4M | $49.6M | $60.9M | $61.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$4.9M | $19.4M | $49.6M | $60.9M | $61.5M | |
Total Liabilities and Equity | $1.2M | $21.3M | $52.9M | $74.7M | $77.7M | |
Cash and Short Terms | $829.9K | $12.8M | $29M | $2.3M | $7M | |
Total Debt | -- | -- | -- | -- | $6.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.9M | $36.3M | $12.6M | $6M | $2.8M | |
Short Term Investments | -- | $44.6K | $9.3K | $60.2K | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $1M | |
Inventory | -- | -- | -- | $622.6K | $253K | |
Prepaid Expenses | $489.4K | $400.9K | $1.6M | $450.8K | $1.8M | |
Other Current Assets | -- | -- | -- | $242.9K | -- | |
Total Current Assets | $7.4M | $36.8M | $14.4M | $10.3M | $23.3M | |
Property Plant And Equipment | $1.2M | $16M | $33M | $74M | $52.4M | |
Long-Term Investments | $35.3K | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | $3.8M | $3.9M | $4.6M | $766.7K | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $9.5M | $56.6M | $57.4M | $89.3M | $76.5M | |
Accounts Payable | $635.4K | $3.5M | -- | $2.9M | $664.7K | |
Accrued Expenses | -- | -- | -- | $3.2M | $3.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $86K | $112.2K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $841.1K | $3.7M | $3.3M | $17M | $10.6M | |
Long-Term Debt | $256K | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1M | $3.9M | $3.4M | $19.2M | $10.9M | |
Common Stock | $2.9M | $645.7K | $669K | $55.1K | $88.4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -$14.7M | -$15M | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $8.4M | $52.7M | $53.9M | $70.1M | $65.6M | |
Total Liabilities and Equity | $9.5M | $56.6M | $57.4M | $89.3M | $76.5M | |
Cash and Short Terms | $6.9M | $36.4M | $12.6M | $6.1M | $2.8M | |
Total Debt | -- | -- | -- | -- | $6.7M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$13.3M | -$41.8M | -$33.5M | -$22.2M | -$52.5M | |
Depreciation & Amoritzation | -- | $14.7K | $114.6K | $197.7K | $1.8M | |
Stock-Based Compensation | -- | -- | $1.2M | $9.8M | $14.6M | |
Change in Accounts Receivable | -- | -- | -- | -$320.5K | -$99.6K | |
Change in Inventories | -- | -- | -- | -$125.2K | -$29.1K | |
Cash From Operations | -$3M | -$7.8M | -$10.2M | -$13.4M | -$16.7M | |
Capital Expenditures | -- | -- | -- | -- | $12.7M | |
Cash Acquisitions | -- | -- | -- | -$21.9M | -$279.9K | |
Cash From Investing | -$3.9K | -$7.1M | -$15.1M | -$36.7M | -$13M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$125.7K | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.8M | $1.4M | -- | $6M | $20.3M | |
Long-Term Debt Repaid | -$1.5M | -$1.4M | -- | -- | -$24M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $18.8K | -- | -- | -- | |
Cash From Financing | $3.8M | $26.9M | $41.4M | $23.4M | $34.4M | |
Beginning Cash (CF) | $7.4K | $829.9K | $12.8M | $29M | $2.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $822.6K | $12M | $16.1M | -$26.7M | $4.7M | |
Ending Cash (CF) | $829.9K | $12.8M | $29M | $2.3M | $7M | |
Levered Free Cash Flow | -$3M | -$14.8M | -$25.3M | -$28.2M | -$29.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.9M | -$2.6M | -$5.6M | -$10M | -$11.5M | |
Depreciation & Amoritzation | $2.5K | $12.4K | $55.7K | $64.9K | $1.3M | |
Stock-Based Compensation | -- | -- | $2.6M | $4.6M | $3.3M | |
Change in Accounts Receivable | -- | -- | -$260.9K | $118.9K | -$861.5K | |
Change in Inventories | -- | -- | -- | -$8.1K | -$153.8K | |
Cash From Operations | -$2.5M | -$2.9M | -$3.4M | -$5M | -$10.3M | |
Capital Expenditures | -- | -- | -- | -- | $491.1K | |
Cash Acquisitions | -- | -- | -$6.1M | -$279.9K | -- | |
Cash From Investing | -$812.2K | -$3.8M | -$7.8M | -$495.6K | -$491.1K | |
Dividends Paid (Ex Special Dividend) | -- | -$125.7K | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$59.2K | -- | -- | -$7.2M | -$2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $2.2M | -- | -- | -- | |
Cash From Financing | $9.9M | $474.3K | $12.4M | $3.9M | -$2M | |
Beginning Cash (CF) | $403.7K | $42.5M | $11.4M | $7.6M | $20.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.5M | -$6.2M | $1.1M | -$1.7M | -$12.8M | |
Ending Cash (CF) | $6.9M | $36.3M | $12.6M | $6M | $7.8M | |
Levered Free Cash Flow | -$3.3M | -$6.7M | -$5.2M | -$6.2M | -$10.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$43.6M | -$32.3M | -$21.1M | -$37M | -$60M | |
Depreciation & Amoritzation | -- | $43.7K | $220K | $252.4K | $5.4M | |
Stock-Based Compensation | -- | -- | $7.3M | $16M | $15.1M | |
Change in Accounts Receivable | -- | -- | -$276.2K | -$251.5K | -$684.8K | |
Change in Inventories | -- | -- | -- | -$622.5K | -$2.5M | |
Cash From Operations | -$6.4M | -$9.8M | -$13.7M | -$15M | -$27.4M | |
Capital Expenditures | -- | -- | -- | -- | $2.9M | |
Cash Acquisitions | -- | -- | -$6.1M | -$16.1M | -- | |
Cash From Investing | -- | -$16.3M | -$22.1M | -$30.1M | -$3.6M | |
Dividends Paid (Ex Special Dividend) | -- | -$125.7K | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.8M | -- | -- | $26.3M | $9.9M | |
Long-Term Debt Repaid | -$2.7M | -- | -- | -$18.6M | -$12.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $14.5M | $55.5M | $12.1M | $38.5M | $32.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.4M | $29.4M | -$23.7M | -$6.6M | $1.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$6.4M | -$26.1M | -$29.8M | -$29.6M | -$30.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$36.1M | -$26.7M | -$14.2M | -$29.1M | -$36.6M | |
Depreciation & Amoritzation | $7.7K | $36.8K | $142.2K | $196.9K | $3.8M | |
Stock-Based Compensation | -- | -- | $6.1M | $12.3M | $12.8M | |
Change in Accounts Receivable | -- | -- | -$276.2K | -$207.3K | -$792.5K | |
Change in Inventories | -- | -- | -- | -$497.3K | -$3M | |
Cash From Operations | -$5.2M | -$7.3M | -$10.8M | -$12.4M | -$23.1M | |
Capital Expenditures | -- | -- | -- | -- | $2M | |
Cash Acquisitions | -- | -- | -$6.1M | -$279.9K | -- | |
Cash From Investing | -$1.7M | -$11M | -$18M | -$11.4M | -$2M | |
Dividends Paid (Ex Special Dividend) | -- | -$125.7K | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.4M | -- | -- | $20.3M | $9.9M | |
Long-Term Debt Repaid | -$1.8M | -- | -- | -$18.6M | -$7.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | $811K | |
Cash From Financing | $13.1M | $41.7M | $12.4M | $27.5M | $25.9M | |
Beginning Cash (CF) | $2.5M | $101.3M | $61.3M | $15.3M | $33.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.1M | $23.5M | -$16.4M | $3.7M | $847.5K | |
Ending Cash (CF) | $8.6M | $124.8M | $44.9M | $19M | $34.2M | |
Levered Free Cash Flow | -$7M | -$18.2M | -$22.7M | -$24.2M | -$25.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.